This report focuses on the global Tuberculosis Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Tuberculosis Diagnostics development in United States, Europe and China. Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms. The classification of Tuberculosis diagnostics includes culture-based diagnostics, sputum smear microscopy diagnostics, rapid molecular diagnostics and so on. And the proportion of Culture-based Diagnostic in 2017 is about 34.84%, and the proportion is in decreasing trend from 2013 to 2017. Tuberculosis Diagnostics is widely used in hospital, diagnostic laboratories and other field. The most proportion of Tuberculosis Diagnostics is hospital, and the revenue in 2017 is 542 M USD. Europe is the largest consumption place, with a Revenue market share nearly 42.03% in 2017. Following Europe, Africa is the second largest consumption place with the Revenue market share of 35.76%. In 2017, the global Tuberculosis Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025. The key players covered in this study Danaher Roche Thermo Fisher Scientific BD Abbott Hologic Qiagen BioMerieux Hain Lifescience Oxford Immunotec Epistem Akonni Biosystems Creative Diagnostics Market segment by Type, the product can be split into Culture-based Sputum Smear Microscopy Rapid Molecular Others Market segment by Application, split into Hospital Diagnostic Laboratories Others Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Tuberculosis Diagnostics status, future forecast, growth opportunity, key market and key players. To present the Tuberculosis Diagnostics development in United States, Europe and China. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by product type, market and key regions. In this study, the years considered to estimate the market size of Tuberculosis Diagnostics are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Tuberculosis Diagnostics Market Size Growth Rate by Type (2013-2025) 1.4.2 Culture-based 1.4.3 Sputum Smear Microscopy 1.4.4 Rapid Molecular 1.4.5 Others 1.5 Market by Application 1
